Search – Page 81 – Indianapolis Business Journal

Home » Search

Articles

State using big data to attack opioid epidemic

May 26, 2017

Indiana’s Management Performance Hub is organizing and analyzing data to help state agencies make better decisions about fighting the opioid scourge and other systemic problems.

Brown calls genomics startup ‘riskiest thing I’ve ever done’

May 25, 2017

LifeOmic is seeking to help doctors provide more precise treatments for patients by sequencing their DNA.

Indy boasts innovations others could copy

May 25, 2017

It’s tough to look at your own community and figure out what it’s doing that no one else is. But IBJ gave it a shot. Here are four things other cities could copy from us.

Lilly Endowment assets ebb in 2016 as it grants $452.8M

May 22, 2017

After several years in which the value of its assets swelled, philanthropic giant Lilly Endowment Inc. watched its coffers shrink 12.7 percent in 2016 from about $11.8 billion to $10.3 billion.

Lilly hires ‘powerhouse’ D.C. lobbyist

May 18, 2017

Leigh Ann Pusey will join Eli Lilly and Co. next month as senior vice president for corporate affairs and communications.

Lilly migraine drug provides relief in late-stage trials

May 12, 2017

Lilly is in a race with several pharmaceutical firms to develop migraine treatments using an approach known as anti-CGRP and that could create a multibillion-dollar market.

MORRIS: Lawyers who make a positive impact

May 11, 2017

This year’s Leadership in Law class honors those whose work touches the community.

Pharma lobbying group ousts 22 drugmakers amid U.S. pricing debate

May 10, 2017

The pharmaceutical industry’s powerful Washington, D.C., trade association, which includes Eli Lilly and Co., fell in size by almost two dozen companies after revising membership rules amid the debate over U.S. drug prices.

Franklin College builds on life sciences legacy with new $18M science center

May 8, 2017

The small Johnson County college has turned out its share of science graduates over the decades, and says the expansion will continue to attract students.

Drug lobby mulling membership reductions amid price scrutiny

May 8, 2017

The lobby group, Pharmaceutical Research and Manufacturers of America—which counts Eli Lilly and Co. as a member—is proposing that to remain a member, companies will have to spend $200 million a year on research and development.

Transcript of April 28, 2017, Life Sciences Power Breakfast panel discussion

May 5, 2017

IBJ’s Life Sciences Power Breakfast was held April 28, 2017, at the Marriott downtown. Here’s the full transcript.

Lilly executive Pescovitz leaving to become university president

May 5, 2017

Oakland University in suburban Detroit on Thursday announced that its board of trustees unanimously chose Ora Hirsch Pescovitz for the job after a search involving more than 60 candidates.

Life sciences firms see some fundraising success but need massive sums

May 4, 2017 | John Russell

Around Indiana, life sciences companies are searching high and low for venture capital to fund promising but expensive new products, which can take a decade or longer to develop.

Flooding from rains prompts closure of Indianapolis monument

May 4, 2017

Days of heavy rainfall have forced the temporary closure of downtown Indianapolis’ historic Soldiers and Sailors Monument.

Despite setbacks, top Lilly researcher bullish on pipeline’s momentum

April 28, 2017

The Indianapolis drugmaker is trying to reassure Wall Street that its pipeline is still poised to deliver.

Biz interests mostly pleased with legislative session

April 28, 2017

Although lawmakers OK’d less than half the $50 million annual pledge business leaders wanted for expanding state-funded preschool, they passed a major infrastructure bill that businesses favored.

Career includes IT, restaurants and more

April 27, 2017

Clyde Harris says he’s had the “craziest career you have ever seen, from politics to acting in front of the camera to writing scripts to sales.”

Lilly diabetes drug Jardiance falls short of quarterly sales predictions

April 25, 2017

Shares in Eli Lilly and Co. stock fell more than 3 percent Tuesday after the Indianapolis-based drugmaker released a quarterly earnings report that showed sales of potential blockbuster drug Jardiance missed expectations by a wide margin.

Lilly profit climbs 18 percent after one-time expenses